A clinically applicable molecular-based classification for endometrial cancers A Talhouk, MK McConechy, S Leung, HH Li-Chang, JS Kwon, N Melnyk, ... British journal of cancer 113 (2), 299-310, 2015 | 756 | 2015 |
Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond S Hansford, P Kaurah, H Li-Chang, M Woo, J Senz, H Pinheiro, ... JAMA oncology 1 (1), 23-32, 2015 | 720 | 2015 |
Confirmation of ProMisE: a simple, genomics‐based clinical classifier for endometrial cancer A Talhouk, MK McConechy, S Leung, W Yang, A Lum, J Senz, N Boyd, ... Cancer 123 (5), 802-813, 2017 | 717 | 2017 |
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series S Kommoss, MK McConechy, F Kommoss, S Leung, A Bunz, J Magrill, ... Annals of Oncology 29 (5), 1180-1188, 2018 | 534 | 2018 |
New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care A Talhouk, JN McAlpine Gynecologic oncology research and practice 3, 1-12, 2016 | 225 | 2016 |
Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: earlier prognostic information to guide treatment A Talhouk, LN Hoang, MK McConechy, Q Nakonechny, J Leo, A Cheng, ... Gynecologic oncology 143 (1), 46-53, 2016 | 209 | 2016 |
Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas MK McConechy, A Talhouk, HH Li-Chang, S Leung, DG Huntsman, ... Gynecologic oncology 137 (2), 306-310, 2015 | 204 | 2015 |
Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis MK McConechy, A Talhouk, S Leung, D Chiu, W Yang, J Senz, ... Clinical Cancer Research 22 (12), 2865-2873, 2016 | 188 | 2016 |
Neoadjuvant chemotherapy of ovarian cancer results in three patterns of tumor-infiltrating lymphocyte response with distinct implications for immunotherapy CS Lo, S Sanii, DR Kroeger, K Milne, A Talhouk, DS Chiu, K Rahimi, ... Clinical Cancer Research 23 (4), 925-934, 2017 | 164 | 2017 |
Molecular subtype not immune response drives outcomes in endometrial carcinoma A Talhouk, H Derocher, P Schmidt, S Leung, K Milne, CB Gilks, ... Clinical Cancer Research 25 (8), 2537-2548, 2019 | 119 | 2019 |
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile FKF Kommoss, AN Karnezis, F Kommoss, A Talhouk, FA Taran, ... British journal of cancer 119 (4), 480-486, 2018 | 113 | 2018 |
Interobserver agreement in endometrial carcinoma histotype diagnosis varies depending on The Cancer Genome Atlas (TCGA)-based molecular subgroup LN Hoang, MA Kinloch, JM Leo, K Grondin, CH Lee, C Ewanowich, ... The American journal of surgical pathology 41 (2), 245-252, 2017 | 113 | 2017 |
Prognostic gene expression signature for high-grade serous ovarian cancer J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, ... Annals of oncology 31 (9), 1240-1250, 2020 | 107 | 2020 |
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis JN McAlpine, DS Chiu, RA Nout, DN Church, P Schmidt, S Lam, S Leung, ... Cancer 127 (14), 2409-2422, 2021 | 91 | 2021 |
Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma H Britton, L Huang, A Lum, S Leung, K Shum, M Kale, A Burleigh, J Senz, ... Gynecologic Oncology 153 (3), 487-495, 2019 | 90 | 2019 |
Human papillomavirus (HPV)‐independent vulvar squamous cell carcinoma has a worse prognosis than HPV‐associated disease: a retrospective cohort study JN McAlpine, SCY Leung, A Cheng, D Miller, A Talhouk, CB Gilks, ... Histopathology 71 (2), 238-246, 2017 | 90 | 2017 |
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification AN Karnezis, S Leung, J Magrill, MK McConechy, W Yang, C Chow, ... The Journal of Pathology: Clinical Research 3 (4), 279-293, 2017 | 89 | 2017 |
Synthesis of diagnostic quality cancer pathology images by generative adversarial networks AB Levine, J Peng, D Farnell, M Nursey, Y Wang, JR Naso, H Ren, ... The Journal of pathology 252 (2), 178-188, 2020 | 82 | 2020 |
Morphologic and molecular characteristics of mixed epithelial ovarian cancers R Mackenzie, A Talhouk, S Eshragh, S Lau, D Cheung, C Chow, N Le, ... The American journal of surgical pathology 39 (11), 1548-1557, 2015 | 79 | 2015 |
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study PF Rambau, RA Vierkant, MP Intermaggio, LE Kelemen, MT Goodman, ... The Journal of Pathology: Clinical Research 4 (4), 250-261, 2018 | 76 | 2018 |